✕
Gain access to exclusive preclinical content.
Complete the form below. We'll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
 简体中文
(Simplified Chinese) 繁體中文
(Traditional Chinese)
Noninvasive point-of-care measurement of gastrointestinal permeability
Wednesday, January 8th, 2020
Richard B. Dorshow, J.R. Johnson, Martin P. Debreczeny, “Noninvasive point-of-care measurement of gastrointestinal permeability,” SPIE BiOS, 2019, San Francisco, California, United States.
Development and clinical trial results of a prototype device for trans-cutaneous monitoring of kidney function
Thursday, January 2nd, 2020
M.P. Debreczeny and R.B. Dorshow, “Development and clinical trial results of a prototype device for trans-cutaneous monitoring of kidney function,” Reporters, Markers, Dyes, Nanoparticles, and
Modeling of transdermal fluorescence measurements from first-in-human clinical trials for renal function determination using fluorescent tracer agent MB-102
Monday, December 30th, 2019
K.M. Shultz, M.P. Debreczeny, R.B. Dorshow, J.E. Keating, and K.L. Bechtel, “Modeling of transdermal fluorescence measurements from first-in-human clinical trials for renal function determination using
Application of Fluorescent Tracer Agent Technology to Point-of-Care Gastrointestinal Permeability Measurement
Sunday, December 29th, 2019
Richard B. Dorshow, Jeng-Jong Shieh, Thomas E. Rogers, Carla Hall-Moore, Nurmohammad Shaikh, Michael Talcott, and Phillip I. Tarr, “Application of Fluorescent Tracer Agent Technology to
Results of the First-in-Human Clinical Trial for MB-102, a Novel Fluorescent Tracer Agent for Real-Time Measurement of Glomerular Filtration Rate
Thursday, December 26th, 2019
R.B. Dorshow, M.P. Debreczeny, and T.C. Dowling, “Results of the first-in-human clinical trial for MB-102, a novel fluorescent tracer agent for real-time measurement of glomerular
Initial Formal Toxicity Evaluation of APC-2, a Novel Fluorescent Tracer Agent for Real-Time Measurement of Glomerular Filtration Rate in Preparation for a first-in-man clinical trial
Wednesday, December 25th, 2019
J.E. Bugaj and R.B. Dorshow, “ Initial Formal Toxicity Evaluation of APC-2, a Novel Fluorescent Tracer Agent for Real-Time Measurement of Glomerular Filtration Rate in
Real-time point-of-care measurement of impaired renal function in a rat acute injury model employing exogenous fluorescent tracer agents
Sunday, December 22nd, 2019
Richard B. Dorshow, Richard M. Fitch, Karen P. Galen, Jolette K. Wojdyla, Amruta R. Poreddy, John N. Freskos, Raghavan Rajagopalan, Jeng-Jong Shieh, and Sevag G.
Development of fluorescent tracers for the real-time monitoring of renal function
Thursday, December 19th, 2019
A.R. Poreddy, B. Asmelash, M.P. Debreczeny, R.M. Fitch, J.N. Freskos, K.P. Galen, K.R. Gaston, J.G. Kostelc, R. Kumar, T.A. Marzan, W.L. Neumann, R. Rajagopalan, T.M.
Human skin autofluorescence decay as a function of irradiance and skin type
Wednesday, December 18th, 2019
M.P. Debreczeny, R. Bates, R.M. Fitch, K.P. Galen, J. Ge, and R.B. Dorshow, “Human skin autofluorescence decay as a function of irradiance and skin type,”
N-Alkylated amino pyrazines for use as hydrophilic optical agents
Sunday, December 15th, 2019
A.R. Poreddy, B. Asmelash, K.P. Galen, R.M. Fitch, J.J. Shieh, J.M. Wilcox, T.M. Schoenstein, J.K. Wojdyla, K.R. Gaston, J.N. Freskos, W.L. Neumann, R. Rajagopalan, H.Y.Ahn,
Fluorescence-enhanced europium complexes for the assessment of renal function
Friday, December 13th, 2019
L.K. Chinen, K.P. Galen, K.T. Kuan, M.E. Dyszlewski, H. Ozaki, H. Sawai, R.S. Pandurangi, F.G. Jacobs, R.B. Dorshow, and R. Rajagopalan, “Fluorescence-enhanced europium complexes for
New optical probes for continuous monitoring of renal function
Thursday, December 12th, 2019
R.B. Dorshow, B. Asmelash, L.K. Chinen, M.P. Debreczeny, R.M. Fitch, J.N. Freskos, K.P. Galen, K.R. Gaston, T.A. Marzan, A.R. Poreddy, R. Rajagopalan, J.-J. Shieh, and

United States
MediBeacon Inc.
425 N. New Ballas Road
Suite 100
St. Louis, MO 63141
P: (314) 269-5808

Germany
MediBeacon GmbH
Cubex41
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
P: +49 (0)621-150283-15

Greater China
(Exclusive Commercial Partner)
Huadong Medicine Co., Ltd
Telephone: 4008-269-985
+86-(0)571-89908581
Zip: 310011
Address: No.866. Moganshan Road, Hangzhou, Zhejiang Province, China
Email: info@eastchinapharm.com

Science How it Works R&D Platform Product Pipeline Patent Estate Preclinical Clinical Focus Areas Nephrology Gastroenterology Ophthalmology Surgery In Discovery
Publications MediBeacon Publications Preclinical Publications Industry Literature Company History People By the Numbers Quality Commitment News/Media Contact Get Updates Investors General Questions

*MediBeacon products are in various stages of clinical development and are not yet approved for human use.

**The Transdermal GFR Measurement System (TGFR) is intended to measure Glomerular Filtration Rate (GFR) in patients with impaired or normal renal function. References on this website to measured kidney function and measured renal function refer to the measured GFR.

Terms and Conditions | Privacy Policy | © 2021 MediBeacon All Rights Reserved.

COOKIE CONSENT: We use cookies and similar technologies to recognize your repeat visits and preferences, as well as to analyze traffic, among other things. To learn more about cookies, view our Privacy Policy. By clicking “I Accept” on this banner, or using our site, you consent to the use of cookies unless you have disabled them.